Pharm
Budesonide for Inflammatory Bowel Disease
search
Budesonide for Inflammatory Bowel Disease
, Rectal Budesonide, Oral Budesonide, Uceris, Enterocort EC
See Also
Ulcerative Colitis
Crohns Disease
Rectal Hydrocortisone
Indications
Ulcerative Colitis
Crohns Disease
Eosinophilic Esophagitis
(off label, viscous suspension)
Mechanism
Budesonide (oral, rectal) delivers local steroid primarily to
Gastrointestinal Tract
Each Budesonide formulation targets specific regions of the colon
High first pass metabolism of Oral Budesonide significantly limits any
Systemic Corticosteroid
effects
Dosing
Background
All budesonide forms are expensive ($700 to $1600 in 2023)
Dosing is for adults unless otherwise specified
Decrease dose in severe liver
Impairment
Budesonide Rectal Foam (Uceris Rectal Foam)
Delivers 2 mg/actuation (with 14 doses per canister)
Indicated for active disease in distal colon (induction)
Affects only distal colon (last 15 to 20 cm)
Dose
Start 1 actuation (2 mg) twice daily (in am, and at bedtime) for 2 weeks
Next 1 actuation (1 mg) once daily at bedtime for 4 weeks
Budesonide Capsules (Enterocort EC)
Available as 3 mg capsule
May open capsules and sprinkle on soft food
Indicated for active
Crohns Disease
in right colon (induction)
Affects distal ileum and right colon
Dosing: Adults and children age >= 9 years
Take 9 mg orally daily for 8 weeks
May repeat 8 week course if needed in adults
May finish with taper dose at 6 mg for additional 2 weeks
Dosing: Child age <8 years (off-label)
Give 0.45 mg/kg up to 9 mg orally daily for 8 weeks
Budesonide Extended Release Tablets (Uceris XR Tablets)
Indicated for active disease throughout the colon (induction)
Dosing: Adults and children age >= 9 years
Take 9 mg orally daily each morning for up to 8 weeks
Budesonide Viscous Suspension
Indicated in
Eosinophilic Esophagitis
Dose 2 mg orally daily
Decrease to 1 mg orally daily in age <10 years or height <5 feet
Safety
Pregnancy Category C
Unknown safety in
Lactation
Resources
Budesonide Capsule (DailyMed)
https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=2c2ce3a8-7125-4ee0-afae-73a9cac8fd31
Budesonide Extended Release Tablet (DailyMed)
https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=41d4fd39-81ee-41be-b34d-efb12b3a359d
Budesonide Rectal Foam (DailyMed)
https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=230e4596-2a9b-4d55-b0a0-0cabbcff5289
References
Hamilton (2020) Tarascon Pocket Pharmacopoeia
(2022) Treatment of Mild to Moderate
Ulcerative Colitis
, Presc Lett, #350406
(2023) Drugs for
Inflammatory Bowel Disease
, Med Lett Drug Ther 65: 105-12
Type your search phrase here